ALB and neoplasm: To develop albumin NCs with bone‐tumor targeting ability, human serum albumin (HSA) was adopted as a core framework because of its excellent tumor‐homing ability,19 and TPP was conjugated to HSA to endow targeting ability to the bone tumor microenvironment (TME) (Figure 1).